评价指南中11种中成药防治冠心病PCI术后支架内再狭窄的疗效To Evaluate the Efficacy of 11 Kinds of Chinese Patent Medicines in Guide in the Treatment of In-Stent Restenosis after PCI for Coronary Heart Disease
唐晓洁, 安冬青
临床医学进展Vol.14 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.141251, January 30 2024
早期应用依洛尤单抗对经皮冠状动脉介入术后的超高危动脉粥样硬化性心血管疾病患者发生心血管事件的影响Effect of Early Use of Enwolocumab on Cardiovascular Events in Patients with Extremely-High-Risk Atherosclerotic Cardiovascular Disease after Percutaneouscoronary Intervention
王有志, 谢一兵, 高 亮, 李 鹏
临床医学进展Vol.13 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.132186, February 8 2023
经皮冠状动脉介入治疗联合主动脉球囊反搏治疗急性心肌梗死合并心功能不全预后的危险因素分析Analysis of Prognostic Risk Factors of Patients with Acute Myocardial Infarction Complicated with Cardiac Insufficiency Treated by Percutaneous Coronary Intervention Combined with Intra-Aortic Balloon Counterpulsation
秦仕婷, 潘娜娜, 谭丽娟
临床医学进展Vol.12 No.6, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.126770, June 15 2022
冠心病经皮冠状动脉介入术后支架内再狭窄的中医研究进展Progress of Chinese Medicine Research on In-Stent Restenosis after Percutaneous Coronary Intervention for Coronary Artery Disease
迪达尔·巴合提, 赵亚楠, 韩 轶
临床医学进展Vol.14 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.142389, February 8 2024
经皮冠状动脉介入治疗术后支架内再狭窄因素的探讨Discussion on the Factors of In-Stent Restenosis after Percutaneous Coronary Intervention
马博博, 王晨霞
临床医学进展Vol.11 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.118533, August 25 2021
通过血管内超声评估冠脉支架贴壁不良的研究进展Research Advances in the Assessment of Stent Malapposition in Coronary Artery by Intravascular Ultrasound
武晓龙, 王奖荣, 王 聪, 侯应龙 国家自然科学基金支持
临床医学进展Vol.13 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13122631, December 6 2023